Want to see JP:2385 full AI Analyst Report?
Soiken Holdings Inc. (2385) AI Stock Analysis
Soiken Holdings Inc.
(TSE/TYO:2385)
The company's primary strength is its pristine, debt-free balance sheet, which provides significant financial stability. The high dividend yield of 4.5% is also a major positive, offering tangible shareholder returns. These factors are weighed against the critical weakness of a multi-year revenue decline, which raises substantial concerns about future growth and justifies a cautious overall score. Technicals are neutral-to-weak, reflecting this uncertainty.
Soiken Holdings Inc. (2385) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 5.55B
- Dividend Yield
- 4.72%
- Average Volume (3M)
- 280.59K
- Price to Earnings (P/E)
- 26.1
- Beta (1Y)
- 0.82
- Revenue Growth
- -20.15%
- EPS Growth
- ―
- Country
- Japan
- Employees
- 45
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Biotechnology
Soiken Holdings Inc. Business Overview & Revenue Model
Company Description
Founded in 1994 and headquartered in Toyonaka, Japan, Soiken Holdings Inc. primarily focuses on the advancement of biomarkers. The company’s operations span a diverse range of health and wellness sectors. It is actively involved in the creation and c...
Soiken Holdings Inc. Financial Statement Overview
Summary
Mixed financial profile: a very strong, debt-free balance sheet (85) provides a solid foundation, but this is offset by a weak income statement (45) due to persistent revenue declines, despite a recent return to profitability. Cash flow (60) is improving but has a history of volatility. The overall financial health is stable but growth-challenged.
Income Statement
45NeutralBalance Sheet
85Very PositiveCash Flow
60Neutral| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.85B | 3.87B | 4.85B | 5.16B | 8.08B | 9.35B |
| Gross Profit | 2.41B | 1.87B | 2.41B | 2.48B | 3.72B | 4.26B |
| EBITDA | -192.48M | 287.51M | -201.93M | -583.21M | 750.07M | 1.23B |
| Net Income | -210.41M | 212.29M | -210.70M | -662.20M | 451.85M | 809.71M |
Balance Sheet | ||||||
| Total Assets | 6.81B | 6.85B | 6.81B | 6.96B | 8.24B | 8.49B |
| Cash, Cash Equivalents and Short-Term Investments | 5.26B | 5.65B | 5.26B | 4.79B | 5.95B | 6.22B |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 775.16M | 742.48M | 775.16M | 708.58M | 1.07B | 1.64B |
| Stockholders Equity | 6.02B | 6.11B | 6.02B | 6.23B | 6.97B | 6.65B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 377.20M | 521.19M | -895.42M | -141.08M | 2.09B |
| Operating Cash Flow | 0 | 415.15M | 557.96M | -880.82M | -101.55M | 2.14B |
| Investing Cash Flow | 0 | 119.10M | -389.41M | -14.29M | 160.37M | -244.58M |
| Financing Cash Flow | 0 | -139.80M | -214.00K | -260.71M | -130.21M | -129.94M |
Soiken Holdings Inc. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2385, the sentiment is Negative. The current price of 212.00 is below the 20-day moving average (MA) of 217.85, below the 50-day MA of 219.30, and below the 200-day MA of 230.06, indicating a bearish trend. The MACD of -1.26 indicates Positive momentum. The RSI at 42.13 is Neutral, neither overbought nor oversold. The STOCH value of 15.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:2385.
Soiken Holdings Inc. Peers Comparison
Overall Rating
- JP:238562Neutral
JP:489156Neutral
JP:218350Neutral
JP:234250Neutral
JP:206A49Neutral
JP:237045Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| JP:2385 | 62Neutral | JPY 5.55B | 26.11 | ― | 4.72% | -20.15% | ― |
| JP:4891 | 56Neutral | JPY 6.54B | -6.22 | ― | ― | ― | ― |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| JP:2183 | 50Neutral | JPY 4.52B | -1.19 | ― | 4.00% | -21.55% | -497.97% |
| JP:2342 | 50Neutral | JPY 3.63B | 112.09 | ― | ― | 2.37% | ― |
| JP:206A | 49Neutral | JPY 4.89B | -5.57 | ― | ― | 84.23% | 33.14% |
| JP:2370 | 45Neutral | JPY 5.69B | -4.93 | ― | ― | 12.73% | 25.71% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:2385 | Soiken Holdings Inc. | 212.00 | 36.47 | 20.78% | |
| JP:2183 | Linical Co., Ltd. | 200.00 | -131.75 | -39.71% | |
| JP:2342 | Trans Genic Inc. | 215.00 | 24.00 | 12.57% | |
| JP:2370 | MEDINET Co., Ltd. | 20.00 | -14.00 | -41.18% | |
| JP:4891 | TMS Co., Ltd. | 135.00 | -4.00 | -2.88% | |
| JP:206A | PRISM BioLab Co. LTD | 132.00 | -5.00 | -3.65% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 26, 2026